Bafna Pharmaceuticals Ltd

Pharmaceuticals - Indian - Formulations

NSE: BAFNAPH Small Cap ISIN: INE878I01022
As on 01 November 2024 at 00:00
As on 01 November 2024 at 00:00
80.13
+1.57
(2.00%)
Over 1 Month
-4.28%
Over 6 Months
-19.47%
Over 1 Year
-7.68%
Over 3 Years
-36.05%
Summary
Close 80.13
Open 82.46
High 82.47
Low 80
Volume 1,916
Net Turnover 1,54,180.55
52 Week High 113
52 Week Low 73.25
52Wk High / Low
73.25
113
Key Financial Data
Market Cap (in ₹ Cr) 189.56
EPS 0.26
Book Value (BV) 34.17
Div. Yield -
P/E 308.19
Price/Book Value 2.34
Delivery % 100
Face Value 10
Key Ratios
P/E ratio 24.65
P/B ratio 2.24
EV to Sales 1.34
PEG Ratio -0.70
ROA 6.85
ROE 5.74
Debt-Equity 0.31
Net Profit Margin 4.82
Operating Profit Margin 9.60

Peer Comparison

Company LTP Market Cap (in ₹ Cr)
Bafna Pharmaceuticals Ltd ₹80.13 ₹189.56
Sun Pharmaceuticals Industries Ltd ₹1,858.70 ₹4,45,964.39
Divis Laboratories Ltd ₹5,901 ₹1,56,653.01
Cipla Ltd ₹1,559.20 ₹1,25,920.28
Torrent Pharmaceuticals Ltd ₹3,207.70 ₹1,08,558.27
Mankind Pharma Ltd ₹2,690.55 ₹1,07,795.31

News

Bafna Pharmaceuticals schedules AGM

On 25 September 2024

05 Sep 2024

Bafna Pharmaceuticals to convene AGM

On 25 September 2024

04 Sep 2024

Bafna Pharmaceuticals to declare Quarterly Result

On 13 August 2024

10 Aug 2024

Bafna Pharmaceuticals to hold board meeting

On 29 May 2024

28 May 2024

Bafna Pharmaceuticals to declare Quarterly Result

On 12 February 2024

03 Feb 2024

Financials

Profit and Loss

Particulars (in ₹ Cr.) FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Total Revenue 155.99 118.62 86.84 71.97 42.73
Total Expenses 148.64 107.01 79.47 66.14 44.61
Profit Before Tax 7.35 11.62 5.22 5.83 -1.88
Profit After Tax 7.35 11.34 5.22 5.83 -1.88
Operating Profit after Depreciation 9.64 13.65 8.17 6.57 -1.78

Balance Sheet

Particulars (in ₹ Cr.) FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Fixed Assets 41.98 41.73 38.85 35.97 34.97
Total Non Current Assets 53.21 42.27 39.26 36.80 35.18
Total Current Assets 94.47 87.31 50.88 49.67 35.88
TOTAL ASSETS 147.68 129.58 90.14 86.47 71.06
Total Shareholder's Fund 80.84 73.45 61.96 56.77 50.95

Cash Flow

Particulars (in ₹ Cr.) FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Net Cash from Operating Activities 9.48 4.95 9.73 -13.61 -34.27
Net Cash used in Investing Activities -15.05 -7.49 -6.54 -5.35 32.78
Net Cash used in Financing Activities -0.85 10.18 -4.81 12.28 7.27

Corporate Actions

No available data

FAQ’s

What is the share price of Bafna Pharmaceuticals Ltd today?
Bafna Pharmaceuticals Ltd share price as on 3 Nov 2024 is ₹80.13
What is the Market Cap of Bafna Pharmaceuticals Ltd?
The market cap of Bafna Pharmaceuticals Ltd stock is ₹189.56 Cr.
What is the PE Ratio of Bafna Pharmaceuticals Ltd?
The Price to Earnings (P/E) Ratio of Bafna Pharmaceuticals Ltd is 24.65
What is the PB Ratio of Bafna Pharmaceuticals Ltd?
The Price to Book (P/B) Ratio of Bafna Pharmaceuticals Ltd is 2.24
What is the 52 week high of Bafna Pharmaceuticals Ltd?
The 52 week high of Bafna Pharmaceuticals Ltd is ₹113
What is the 52 week low of Bafna Pharmaceuticals Ltd?
The 52 week low of Bafna Pharmaceuticals Ltd is ₹73.25

Get started with us today and
start building your wealth journey